Pathogenic mycobacterium upregulates cholesterol 25-hydroxylase to promote granuloma development via foam cell formation
Shuang Zhou,Ding Zhang,Dan Li,Hankun Wang,Cairong Ding,Jingrui Song,Weifeng Huang,Xuan Xia,Ziwei Zhou,Shanshan Han,Zhu Jin,Bo Yan,Jacqueline Gonzales,Laura E. Via,Lu Zhang,Decheng Wang
DOI: https://doi.org/10.1016/j.isci.2024.109204
IF: 5.8
2024-03-01
iScience
Abstract:Pathogenic mycobacteria orchestrate the complex cell populations known as granuloma that is the hallmark of tuberculosis. Foam cells, a lipid-rich cell-type, are considered critical for granuloma formation; however, the causative factor in foam cell formation remains unclear. Atherosclerosis is a chronic inflammatory disease characterized by the abundant accumulation of lipid-laden-macrophage-derived foam cells during which cholesterol 25-hydroxylase (CH25H) is crucial in foam cell formation. Here, we show that <i>M</i>. <i>marinum</i> (<i>Mm</i>), a relative of <i>M</i>. <i>tuberculosis</i>, induces foam cell formation, leading to granuloma development following CH25H upregulation. Moreover, the <i>Mm</i>-driven increase in CH25H expression is associated with the presence of phthiocerol dimycocerosate, a determinant for <i>Mm</i> virulence and integrity. CH25H-<i>null</i> mice showed decreased foam cell formation and attenuated pathology. Atorvastatin, a recommended first-line lipid-lowering drug, promoted the elimination of <i>M. marinum</i> and concomitantly reduced CH25H production. These results define a previously unknown role for CH25H in controlling macrophage-derived foam cell formation and Tuberculosis pathology.
multidisciplinary sciences